that several human papilloma viruses (HPVs) types, are responsible for cervical cancer. 4 Indeed, they have been related with more than 90% of cervical cancers. 5 HIV affected women possess 6 times more risk of cervical cancer compared to general population. 6 There is a likely of this cancer for women who use oral contraceptive for more than 5 years in comparison to never users. 7 Parous women possess 64% chance having 7+ full term pregnancies versus women with 1 or 2. Current smokers have higher cervical cancer risk as they come in contact of HPV infection or HPV-infected cells tend to cancerous progression by smoking. 8 Cervical cancer risk is privileged in those of vaginal, kidney, urinary tract, or skin cancers. 9, 10 Carcinoma risk in squamous cell in cervix is 74-80% privileged in women with their relative like mother, sister, daughter in comparison with general women. 11 In high-income countries the incidence rates were similar as those in the developing world since 1960 and 1970s. Efficient screening programs turn down incidence and mortality rates in first world countries.
12 CYP3A4*1B gene notably increased lung cancer risk was only found for homozygous CYP3A5*1 allele but not for heterozygotes. 13 Moreover CYP3A4*1B polymorphism might raise the risk of cancer prostate cancer among African populations.
14 This allele is not related with breast or ovarian cancer. To maintain of this negative result, invitro functional analysis shows that NFSE genotype is not a vital factor in the transcriptional activity of the CYP3A45-flanking region. 15 Another study recommended that CYP3A4*1B was related with markers of complex disease. These observations maintain the belief that progress of strong, conservative molecular epidemiologic case-control studies to deal with gene-gene and gene-environment interactions, will be timely. 16 No samples were positive in Bangladeshi tuberculosis patients for CYP3A4*2, CYP3A4*4, CYP3A4*5, CYP3A4*6, CYP3A4*10, and CYP3A4*18 alleles. A particular sample was establish to be heterozygous for CYP3A4*1B (1.11%).
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METHODS
National Institute of Cancer Research and Hospital
Mohakhali, Dhaka approved this hospital-based casecontrol study. Thirty diagnosed, histologically established cervical cancer patients were successively recruited between August 2014 and December 2014.
A total of 30 healthy control subjects were selected matching for age, marital status, previous cancer history, former screening experience were collected for comparison. Control and patients were not relative to each other. Interviews were done by qualified nurses in the company of proficient physicians. All patients were announced about the study, and their assent to participate in this study was achieved on a predesigned feedback form.
DNA extraction and primer construction
3 ml venous blood of all patients and control were collected in sterile tubes containing EDTA-Na 2 and preserve at -80°C until DNA isolation. Daly's chemical method was used to isolate Genomic DNA. 18 150 µl of blood mixed up with 1ml cell lysis buffer, centrifuged at 4,000 rpm for 7.5 min, and the resultant precipitate (nucleus) was mixed with 100 µl nuclear lysis buffer and 25-µl of 5 M Sodium perchlorate.
To dissolve the precipitate accurately, the mixture was incubated at 37°C for 30 min. To precipitate the protein Chloroform (125 µl) was added. After precipitation, the mixture was rotated in a rotary mixture (10 min, 30 rpm, at room temperature). Collected clear aqueous supernatant was mixed with two times amount of ethanol in order to disclose the white cotton like pellet (DNA) and collected the white cotton like pellet using disposable microbiology loop. DNA was preserved in 200 µl TE buffer and kept the tube at 65°C overnight. The total DNA solution preserved at -20°C freezer until PCR.
Polymerase chain reaction-restriction fragment length polymorphism
Briefly, 26μl PCR mixture consisted of 1μl genomic DNA samples (50-70 ng/μl), 20μl of ×10 standard Taq reaction buffer (with MgCl 2 ), 4.0 μl dNTPs (2.5 mM), 2.0μl of each primer (10 µM), 1.0 μl of Taq DNA polymerase (5.0 U/µl) (Jena Bioscience, Germany), and 180μl nuclease free water. The typical program was followed for PCR amplification as follows:
One initial denaturation step at 94°C for 1 min, accompanied by 35 denaturation cycles of 30s at 94 °C, 30s of annealing at 60°C, and 30s of extension at 72°C, accompanied by a final elongation cycle at 72°C for 1 min. By staining the PCR product with ethidium bromide, it was analyzed on a 3% agarose gel. For RFLP, the PCR products of CYP3A4*1B were digested with Mbo II (New England Bio Labs). For resolution DNA fragments were analyzed through 5% agarose gel (Figure 1 ).
Statistical analysis
Using chi-square tests and Student's t tests, the demographic variables of cases and controls were compared. The association between CYP3A4*1B allele and cervical cancer risks were assessed using the odds ratio (OR) and 95% CI (confidence intervals) ( Table 4) . Odds ratio (OR) and 95% CI (confidence intervals) was determined applying conditional logistic regression analysis with correction for age, smoking status, and sex by means of the statistical software package SPSS version 20.0. p<0.05 was measured statistically significant. 
RESULTS
Case and control characteristics
A total of 30 cervical cancer patients and 30 controls were recruited into the study. Of the 30 cervical cancer cases, 23 (76.67%) had no family history of cancer and 07 (23.33%) possessed previous cancer history in the patients group compared to 27 (90.00%) and 03 (10.00%) with control group respectively. Only 02 (6.67%) patients were smoker and the other 28 (93.33%) were non-smoker in comparison with 01 (3.33%) smoker and 29 (96.67%) non-smoker correspondingly. Most of the patients (70.00%) were poor since their monthly incomes were less than 4500 taka ( Our study gone through several limitations. First, we could not appraise the associations between genotypes and phenotypes of CYP3A4*1B. Subsequent, the quantity of issues in our study was restrained, and the statistical supremacy of the study was narrow. Third, we did not able to collect tissue sample due to lacking of such facilities.
Tissue sample is necessary for HPV typing. HPV infection is a crucial pathogenic factor for cervical cancer. It is expected that associations may be firmer with one particular subtype than another. Consequently, the study subjects, mainly cancer cases, may not be delegated for the target population, and our conclusions might not be unrealizable to the general population. Lastly, our findings require to be interpreted with care, and the associations need to be simulated in bigger, preferably population-based studies.
CONCLUSION
In brief, the consequences of our study demonstrated that CYP3A4*1B polymorphism is not allied in susceptibility
